ITRM960808A1 - Immunoconiugati comprendenti anticorpi monoclonali umani o frammenti di essi per diagnosi in vivo e terapia - Google Patents

Immunoconiugati comprendenti anticorpi monoclonali umani o frammenti di essi per diagnosi in vivo e terapia

Info

Publication number
ITRM960808A1
ITRM960808A1 IT96RM000808A ITRM960808A ITRM960808A1 IT RM960808 A1 ITRM960808 A1 IT RM960808A1 IT 96RM000808 A IT96RM000808 A IT 96RM000808A IT RM960808 A ITRM960808 A IT RM960808A IT RM960808 A1 ITRM960808 A1 IT RM960808A1
Authority
IT
Italy
Prior art keywords
fragments
therapy
monoclonal antibodies
human monoclonal
including human
Prior art date
Application number
IT96RM000808A
Other languages
English (en)
Original Assignee
Rossolini Gianmaria
Cresti Stefania
Thaller Maria Cristina
Selan Laura
Passariello Claudio
Schippa Serena
Cattani Paola
Berlutti Francesca
Isprobi S Rl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rossolini Gianmaria, Cresti Stefania, Thaller Maria Cristina, Selan Laura, Passariello Claudio, Schippa Serena, Cattani Paola, Berlutti Francesca, Isprobi S Rl filed Critical Rossolini Gianmaria
Priority to IT96RM000808A priority Critical patent/ITRM960808A1/it
Publication of ITRM960808A0 publication Critical patent/ITRM960808A0/it
Priority to PCT/IT1997/000296 priority patent/WO1998023286A2/en
Priority to AU51354/98A priority patent/AU5135498A/en
Publication of ITRM960808A1 publication Critical patent/ITRM960808A1/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1027—Paramyxoviridae, e.g. respiratory syncytial virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
    • A61K47/6839—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting material from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1006—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody the antibody being against or targeting material from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
IT96RM000808A 1996-11-26 1996-11-26 Immunoconiugati comprendenti anticorpi monoclonali umani o frammenti di essi per diagnosi in vivo e terapia ITRM960808A1 (it)

Priority Applications (3)

Application Number Priority Date Filing Date Title
IT96RM000808A ITRM960808A1 (it) 1996-11-26 1996-11-26 Immunoconiugati comprendenti anticorpi monoclonali umani o frammenti di essi per diagnosi in vivo e terapia
PCT/IT1997/000296 WO1998023286A2 (en) 1996-11-26 1997-11-26 Immunoconjugates comprising human monoclonal antibodies or fragments thereof for diagnostic and therapy
AU51354/98A AU5135498A (en) 1996-11-26 1997-11-26 Immunoconjugates comprising human monoclonal antibodies or fragments thereof for diagnostic and therapy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT96RM000808A ITRM960808A1 (it) 1996-11-26 1996-11-26 Immunoconiugati comprendenti anticorpi monoclonali umani o frammenti di essi per diagnosi in vivo e terapia

Publications (2)

Publication Number Publication Date
ITRM960808A0 ITRM960808A0 (it) 1996-11-26
ITRM960808A1 true ITRM960808A1 (it) 1998-05-26

Family

ID=11404554

Family Applications (1)

Application Number Title Priority Date Filing Date
IT96RM000808A ITRM960808A1 (it) 1996-11-26 1996-11-26 Immunoconiugati comprendenti anticorpi monoclonali umani o frammenti di essi per diagnosi in vivo e terapia

Country Status (3)

Country Link
AU (1) AU5135498A (it)
IT (1) ITRM960808A1 (it)
WO (1) WO1998023286A2 (it)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986001720A1 (en) * 1984-09-13 1986-03-27 Cytogen Corporation Antibody therapeutic agent conjugates
US4861581A (en) * 1986-12-05 1989-08-29 Cancer Biologics, Inc. Detection of necrotic malignant tissue and associated therapy
CA1339415C (en) * 1989-08-24 1997-09-02 Milton David Goldenberg Detection and treatment of infections with immunoconjugates
KR0162259B1 (ko) * 1989-12-05 1998-12-01 아미 펙터 감염성 병변 및 염증성 병변을 검출 및 치료하기 위한 키메라 항체
ES2191016T3 (es) * 1992-09-16 2003-09-01 Scripps Research Inst Anticuerpos monoclonales neutralizantes humanos para el virus respiratorio sincitial.
GB9314623D0 (en) * 1993-07-14 1993-08-25 Nordion Int Inc Localization and therapy with agents directed against prostate specific antigen in breast cancer

Also Published As

Publication number Publication date
ITRM960808A0 (it) 1996-11-26
WO1998023286A3 (en) 1998-07-30
WO1998023286A2 (en) 1998-06-04
AU5135498A (en) 1998-06-22

Similar Documents

Publication Publication Date Title
DE69636760D1 (de) Rekombinanter anti-cd4 antikörper zur menschlichen behandlung
IL110464A0 (en) Novel proteins for the diagnosis, imaging, and therapy of human cancer
DE69529307D1 (de) Ultraschall-Diagnose- und Behandlungssystem
FI973331A7 (fi) Laite luun ultraäänihoitoon
GB9925804D0 (en) Biological materials and method useful in the diagnosis and treatment of diseases
IT1298765B1 (it) Dispositivo diagnostico e di trattamento per denti
NO983183L (no) Blandinger og fremgangsmåte for behandling og diagnose av brystkreft
NO974494D0 (no) Radiomerkede peptider for diagnostikk og terapi
NO983235D0 (no) Fikstur og protese innbefattende samme
NO20034437L (no) Gangliosid-assosierte rekombinante antistoffer og anvendelse derav ved diagnostikk og behandling av tumorer
ES2153665T3 (es) Usos terapeuticos de productos proteicos bactericidas/incrementadores de la permeabilidad (bpi) para la meningococemia humana.
NO994932D0 (no) Blandinger og fremgangsmaater for behandling og diagnose av brystkreft
PT932400E (pt) Derivados de anticonvulsionantes uteis no tratamento da dor neuropatica
ZA200006518B (en) Diarylselenide compounds and their use in human or veterinary medicine and in cosmetics.
ITRM960808A1 (it) Immunoconiugati comprendenti anticorpi monoclonali umani o frammenti di essi per diagnosi in vivo e terapia
NO990303L (no) Lipidbindende proteiner og deres terapeutiske og diagnostiske anvendelse
FI971879A0 (fi) Allogeenisten ja ksenogeenisten proteiinien vasta-aineet, niiden käyttö diagnoosissa ja hoidossa ja menetelmät niiden määrittämiseksi
ID28817A (id) Penggunaan turunan-turunan tetrahidropiridin (atau4-hidropiperidin)-butilazol dalam pembuatan obat untuk perawatan nyeri
GB9828564D0 (en) Materials and methods for the treatment and diagnosis of cancer
SE9503044D0 (sv) Antibodies for use in cancer therapy and diagnosis
EP0561297A3 (en) Tissue antigen and diagnostic method for human osteoporosis using the same
SI1157041T1 (sl) Protitelesa za terapijo in diagnozo raka
GB9614416D0 (en) Antigen for use in cancer therapy and diagnosis
GB9621093D0 (en) Antigen for use in cancer therapy and diagnosis
GB9716787D0 (en) Materials and methods for the diagnosis and treatment of breast cancer

Legal Events

Date Code Title Description
0003 Withdrawn